Man collapses behind Trump during Oval Office announcement

Man Collapses During Trump’s Oval Office Announcement

During a Thursday press conference in the Oval Office, a man collapsed behind President Donald Trump while announcing a deal with drugmakers to lower prices and expand Medicare coverage for obesity treatments Zepbound and Wegovy.

As the man fainted, officials quickly responded. Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz supported the man’s head as he was lowered to the floor. The cause of the collapse was unclear.

White House press secretary Karoline Leavitt said, “During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”

The man, identified as a guest of drug companies Eli Lilly and Novo Nordisk, did not return to the event. About an hour later, President Trump resumed the weight-loss drug announcement.

Trump commented that the man was feeling lightheaded but was now fine. Newsweek sought further comment from the White House via email.

The announcement highlighted a new agreement between President Trump and drugmakers Eli Lilly and Novo Nordisk to expand Medicare coverage and reduce costs for the obesity drugs Zepbound and Wegovy.

Summary

A guest fainted during President Trump’s announcement on lowering obesity drug prices, but recovered quickly, allowing the event to continue with the focus on expanding Medicare coverage.

more

Newsweek Newsweek — 2025-11-06

More News